Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Avenue Therapeutics (OTCID:ATXI) through any online brokerage.
There are no as such competitors for Avenue Therapeutics.
Avenue Therapeutics has a consensus price target of $16.38.
The stock price for Avenue Therapeutics (OTCID: ATXI) is $0.959 last updated October 20, 2025 at 4:00 PM EDT.
There are no upcoming dividends for Avenue Therapeutics.
Avenue Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Avenue Therapeutics.
Avenue Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCID.